Effect on Adaptation to Cancer of Mobile Application Developed for Gynecological Cancer Patients
NCT ID: NCT05131490
Last Updated: 2023-02-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
64 participants
INTERVENTIONAL
2022-09-15
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Symptom Management Education With Mobile Application in Gynecological Cancer Patients Receiving Chemotherapy
NCT06713122
The Effect of Mobile-Based Education Given to Patients Undergoing Gynecological Oncology Surgery on Quality of Life
NCT05694208
The Effect of Cervical Cancer Awareness Education Based on Mobile Application
NCT06252012
The Effect of Mobile Application-Assisted Nursing Services on Symptom Control in Breast Cancer Patients
NCT07200791
Investigation of the Effects of Online Education Application on Gynecological Cancer Patients Receiving Chemotherapy
NCT06574256
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A pilot application will be conducted for 4 weeks with 6 patients regarding the usability of the mobile application and these patients will not be included in the study. At the end of 4 weeks, feedback will be received from the patients participating in the pilot application with the mobile application evaluation form. Necessary changes will be made in the mobile application in line with the feedback.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
Experimental group intervention consists two months a mobile application intervention developed for gynecological cancer patients receiving chemotherapy
A mobile application intervention developed for gynecological cancer patients receiving chemotherapy
The mobile application will consist of modules. It is planned to include four education modules and consultancy modules in the application.
1. Module 1: It will consist of sub-categories with information to be prepared in line with the current literature on gynecological cancer types and treatments applied. There will be information and short videos that will strengthen coping with physical symptoms, especially from chemotherapy.
2. Module 2: In this area, there will be meditation and relaxation/breathing exercises, information on relaxing complementary therapies, anxiety reduction and stress management techniques videos and audio recordings.
3. Module 3: Current developments on gynecological cancers will be included.
4. Module 4: Encouraging recovery stories and videos of cancer survivors will be included.
5. Module 5: Counseling module. This is the area where patients who cannot find answers in the frequently asked questions section can ask questions to the research team.
No intervention
Control group receive routine care.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
A mobile application intervention developed for gynecological cancer patients receiving chemotherapy
The mobile application will consist of modules. It is planned to include four education modules and consultancy modules in the application.
1. Module 1: It will consist of sub-categories with information to be prepared in line with the current literature on gynecological cancer types and treatments applied. There will be information and short videos that will strengthen coping with physical symptoms, especially from chemotherapy.
2. Module 2: In this area, there will be meditation and relaxation/breathing exercises, information on relaxing complementary therapies, anxiety reduction and stress management techniques videos and audio recordings.
3. Module 3: Current developments on gynecological cancers will be included.
4. Module 4: Encouraging recovery stories and videos of cancer survivors will be included.
5. Module 5: Counseling module. This is the area where patients who cannot find answers in the frequently asked questions section can ask questions to the research team.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least primary school graduate
* Volunteering to participate in research
* Being diagnosed with gynecological cancer for the first time (no cancer recurrence)
* Receiving at least one course of chemotherapy and continuing chemotherapy treatment
* Be Eastern Cooperative Oncology Group (ECOG) performance scale score below 3
* Be not have a psychiatric illness
* Owning a smartphone
* Be have internet access and have used any mobile application before
Exclusion Criteria
* Be have not yet received or completed chemotherapy treatment
* Be Eastern Cooperative Oncology Group (ECOG) performance scale score of 3 and above
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pamukkale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Okan Vardar
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pamukkale University
Denizli, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
60116787-020/34123
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.